13F HOLDINGS REPORT
ACORN CAPITAL ADVISORS, LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001636587-25-000043
Total Value
$152.9M
Positions
21
Other Managers
0
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | CGON | 1,131,501 | $29.4M | 19.24% |
| 2 | UROGEN PHARMA LTD | URGN | 1,259,749 | $17.3M | 11.29% |
| 3 | Y-MABS THERAPEUTICS INC | 984241109 | 3,418,995 | $15.4M | 10.09% |
| 4 | PUMA BIOTECHNOLOGY INC | PBYI | 4,131,299 | $14.2M | 9.27% |
| 5 | CANDEL THERAPEUTICS INC | CADL | 2,580,517 | $13.1M | 8.54% |
| 6 | TREVI THERAPEUTICS INC | TRVI | 2,144,844 | $11.7M | 7.67% |
| 7 | TERNS PHARMACEUTICALS INC | TERN | 1,971,264 | $7.4M | 4.81% |
| 8 | ONKURE THERAPEUTICS INC | OKUR | 2,839,674 | $6.8M | 4.44% |
| 9 | CYBIN INC | HELP | 734,394 | $6.2M | 4.03% |
| 10 | BICARA THERAPEUTICS | BCAX | 643,382 | $6.0M | 3.91% |
| 11 | PROTARA THERAPEUTICS INC | TARA | 1,752,115 | $5.3M | 3.47% |
| 12 | CARDIF ONCOLOGY INC | CRDF | 1,408,767 | $4.4M | 2.90% |
| 13 | AURA BIOSCIENCES INC | AURA | 595,744 | $3.7M | 2.44% |
| 14 | VERASTEM INC | VSTM | 779,498 | $3.2M | 2.12% |
| 15 | WHITEHAWK THERAPEUTICS INC | WHWK | 1,139,363 | $2.1M | 1.39% |
| 16 | BIOATLA INC | BCAB | 4,835,111 | $1.9M | 1.25% |
| 17 | MURAL ONCOLOGY PLC | G63365103 | 653,779 | $1.6M | 1.06% |
| 18 | VYNE THERAPEUTICS INC | VYNE | 736,572 | $1.2M | 0.79% |
| 19 | Q32 BIO INC. | QTTB | 803,425 | $1.2M | 0.78% |
| 20 | ACRIVON THERAPEUTICS INC | ACRV | 405,237 | $482,232 | 0.32% |
| 21 | X4 PHARMACEUTICALS INC | XFOR | 153,730 | $292,087 | 0.19% |